Temporal Trends in the Use of Drug-eluting Stents for Approved and Off-label Indications: A Longitudinal Analysis of a Large Multicenter Percutaneous Coronary Intervention Registry
Open Access
- 23 February 2010
- journal article
- research article
- Published by Wiley in Clinical Cardiology
- Vol. 33 (2) , 111-116
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Unrestricted Use of Drug-Eluting Stents Compared With Bare-Metal Stents in Routine Clinical PracticeJACC, 2007
- Stent Thrombosis Redux — The FDA PerspectiveNew England Journal of Medicine, 2007
- Long-Term Outcomes with Drug-Eluting Stents versus Bare-Metal Stents in SwedenNew England Journal of Medicine, 2007
- Prevention of Premature Discontinuation of Dual Antiplatelet Therapy in Patients With Coronary Artery StentsJACC, 2007
- Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting StentsJACC, 2006
- Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysisEuropean Heart Journal, 2006
- Association of a Continuous Quality Improvement Initiative With Practice and Outcome Variations of Contemporary Percutaneous Coronary InterventionsCirculation, 2006
- Public Reporting and Case Selection for Percutaneous Coronary InterventionsJACC, 2005
- Development of a Multicenter Interventional Cardiology Database: The Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) ExperienceJournal of Interventional Cardiology, 2002
- Simple Bedside Additive Tool for Prediction of In-Hospital Mortality After Percutaneous Coronary InterventionsCirculation, 2001